102
Participants
Start Date
February 28, 2014
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Transcutaneous CO2 monitor
Measurement and surveillance of transcutaneous CO2 pressure (PtcCO2) to determine PtcCO2 behavior for each sedation group.
Midazolam
The initial dose was 0.05 mg/kg. Additional doses of 2 mg of midazolam were allowed to reach a score level of three to four in the Observer´s assessment of alertness/ sedation scale.
Propofol
The initial dose was 0.1 mg /kg. Additional doses of 10 mg of propofol were allowed to reach a score level of three to four in the Observer´s assessment of alertness/ sedation scale.
Nalbuphine
The starting dose was 2 mg with additional doses of 1 mg if it was necessary.
Lidocaine
Lidocaine spray was applied to the nasal mucosa and pharynx for bronchoscope nostril insertion, and only in the pharynx for bronchoscope oral insertion. Topical lidocaine was applied using the spray-as-you-go technique, at a maximum dose of 7 mg/kg.
UANL University Hospital, Monterrey
Hospital Universitario Dr. Jose E. Gonzalez
OTHER